Press "Enter" to skip to content

J&J shares nosedive on report it knew of asbestos in Baby Powder

The decline in shares erased about $40 billion from the company’s market capitalisation, with investors worrying about the impact of the report as it faces thousands of talc-related lawsuits.

Original source:

Also Read:   Serum Institute of India says will ship AstraZeneca Covid-19 vaccine to Canada in 'less than a month'